Replies to post #145663 on Biotech Values

[DewDiligence]

Barron’s profiles Miles White, ABT’s CEO in a piece that highlights ABT’s participation in The Global Demographic Tailwind:

#msg-77970916

White will stay on as CEO of ABT after the AbbVie pharma spinoff—he knows that what remains of ABT will be the faster-growing and more exciting of the two successor companies.